It is clear that FGF21 levels become elevated as obesity develops in mice and humans, and are positively correlated with BMI, adiposity, and FGF21 expression levels in adipose tissue (145–149). This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.